Exchange Updates Guidance Letter for Biotech Companies
The Stock Exchange of Hong Kong Limited (the Exchange), a wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited (HKEX), has today (Wednesday) updated its guidance letter related to disclosure in listing documents of biotech companies. The updated Guidance Letter, HKEX-GL107-20, provides guidance on presenting fair, balanced and accurate disclosure and additional expectations on disclosing …
Exchange Updates Guidance Letter for Biotech CompaniesRead More »